| List Name |
Annotation |
Enrichment |
p-value |
| response to metal ion |
AmiGO Browser |
38.53 |
1.24e-03 |
| response to inorganic substance |
AmiGO Browser |
29.97 |
2.06e-03 |
| lymphocyte mediated immunity |
AmiGO Browser |
10.46 |
3.11e-03 |
| leukocyte mediated immunity |
AmiGO Browser |
9.79 |
3.75e-03 |
| enzyme linked receptor protein signaling pathway |
AmiGO Browser |
4.62 |
5.02e-03 |
| immune effector process |
AmiGO Browser |
8.49 |
5.57e-03 |
| phosphate metabolic process |
AmiGO Browser |
2.80 |
5.83e-03 |
| phosphorus metabolic process |
AmiGO Browser |
2.80 |
5.83e-03 |
| negative regulation of signal transduction |
AmiGO Browser |
8.09 |
6.36e-03 |
| post-translational protein modification |
AmiGO Browser |
2.43 |
6.98e-03 |
| regulation of signal transduction |
AmiGO Browser |
3.56 |
7.61e-03 |
| erythrocyte differentiation |
AmiGO Browser |
14.98 |
8.03e-03 |
| protein modification process |
AmiGO Browser |
2.27 |
8.30e-03 |
| B cell differentiation |
AmiGO Browser |
14.19 |
8.91e-03 |
| biopolymer modification |
AmiGO Browser |
2.21 |
0.01 |
| lung development |
AmiGO Browser |
12.08 |
0.01 |
| respiratory tube development |
AmiGO Browser |
11.56 |
0.01 |
| protein amino acid dephosphorylation |
AmiGO Browser |
5.98 |
0.01 |
| immunoglobulin mediated immune response |
AmiGO Browser |
10.24 |
0.02 |
| B cell mediated immunity |
AmiGO Browser |
10.24 |
0.02 |
| dephosphorylation |
AmiGO Browser |
5.32 |
0.02 |
| positive regulation of binding |
AmiGO Browser |
50.57 |
0.02 |
| positive regulation of small GTPase mediated signal transduction |
AmiGO Browser |
50.57 |
0.02 |
| positive regulation of interferon-gamma biosynthetic process |
AmiGO Browser |
50.57 |
0.02 |
| regulation of Rho GTPase activity |
AmiGO Browser |
44.95 |
0.02 |
| liver development |
AmiGO Browser |
44.95 |
0.02 |
| negative regulation of BMP signaling pathway |
AmiGO Browser |
44.95 |
0.02 |
| negative regulation of small GTPase mediated signal transduction |
AmiGO Browser |
44.95 |
0.02 |
| innate immune response |
AmiGO Browser |
8.34 |
0.02 |
| positive regulation of B cell proliferation |
AmiGO Browser |
40.45 |
0.02 |
| regulation of BMP signaling pathway |
AmiGO Browser |
40.45 |
0.02 |
| peptidyl-histidine modification |
AmiGO Browser |
40.45 |
0.02 |
| sensory organ development |
AmiGO Browser |
8.01 |
0.03 |
| cell morphogenesis |
AmiGO Browser |
3.03 |
0.03 |
| cellular structure morphogenesis |
AmiGO Browser |
3.03 |
0.03 |
| zinc ion transport |
AmiGO Browser |
36.78 |
0.03 |
| regulation of DNA repair |
AmiGO Browser |
36.78 |
0.03 |
| negative regulation of cell-cell adhesion |
AmiGO Browser |
36.78 |
0.03 |
| male sex determination |
AmiGO Browser |
36.78 |
0.03 |
| negative regulation of B cell activation |
AmiGO Browser |
36.78 |
0.03 |
| protein amino acid phosphorylation |
AmiGO Browser |
2.67 |
0.03 |
| transmembrane receptor protein serine/threonine kinase signaling pathway |
AmiGO Browser |
7.78 |
0.03 |
| folic acid transport |
AmiGO Browser |
33.71 |
0.03 |
| regulation of cell-matrix adhesion |
AmiGO Browser |
33.71 |
0.03 |
| nucleosome disassembly |
AmiGO Browser |
33.71 |
0.03 |
| regulation of interferon-gamma biosynthetic process |
AmiGO Browser |
33.71 |
0.03 |
| chromatin disassembly |
AmiGO Browser |
33.71 |
0.03 |
| regulation of cell-cell adhesion |
AmiGO Browser |
31.12 |
0.03 |
| interferon-gamma biosynthetic process |
AmiGO Browser |
31.12 |
0.03 |
| regulation of T-helper cell differentiation |
AmiGO Browser |
31.12 |
0.03 |
| B cell activation |
AmiGO Browser |
7.04 |
0.03 |
| positive regulation of DNA metabolic process |
AmiGO Browser |
28.90 |
0.03 |
| protein heterooligomerization |
AmiGO Browser |
28.90 |
0.03 |
| regulation of production of molecular mediator of immune response |
AmiGO Browser |
28.90 |
0.03 |
| cytokine production during immune response |
AmiGO Browser |
28.90 |
0.03 |
| regulation of cytokine production during immune response |
AmiGO Browser |
28.90 |
0.03 |
| spinal cord development |
AmiGO Browser |
28.90 |
0.03 |
| thyroid hormone metabolic process |
AmiGO Browser |
28.90 |
0.03 |
| adaptive immune response |
AmiGO Browser |
6.80 |
0.04 |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
AmiGO Browser |
6.80 |
0.04 |
| cell surface receptor linked signal transduction |
AmiGO Browser |
2.02 |
0.04 |
| cofactor transport |
AmiGO Browser |
25.28 |
0.04 |
| regulation of chemotaxis |
AmiGO Browser |
25.28 |
0.04 |
| regulation of B cell proliferation |
AmiGO Browser |
25.28 |
0.04 |
| lymphocyte differentiation |
AmiGO Browser |
6.32 |
0.04 |
| transmembrane receptor protein tyrosine kinase signaling pathway |
AmiGO Browser |
3.97 |
0.04 |
| L-fucose catabolic process |
AmiGO Browser |
23.80 |
0.04 |
| fucose catabolic process |
AmiGO Browser |
23.80 |
0.04 |
| alpha-beta T cell differentiation during immune response |
AmiGO Browser |
23.80 |
0.04 |
| specification of organ identity |
AmiGO Browser |
23.80 |
0.04 |
| cell-cell signaling during cell fate commitment |
AmiGO Browser |
23.80 |
0.04 |
| induction of an organ |
AmiGO Browser |
23.80 |
0.04 |
| induction |
AmiGO Browser |
23.80 |
0.04 |
| T cell activation during immune response |
AmiGO Browser |
23.80 |
0.04 |
| negative regulation of transcription factor activity |
AmiGO Browser |
23.80 |
0.04 |
| CD4-positive, alpha-beta T cell differentiation during immune response |
AmiGO Browser |
23.80 |
0.04 |
| leukocyte activation during immune response |
AmiGO Browser |
23.80 |
0.04 |
| lymphocyte activation during immune response |
AmiGO Browser |
23.80 |
0.04 |
| cell activation during immune response |
AmiGO Browser |
23.80 |
0.04 |
| T cell differentiation during immune response |
AmiGO Browser |
23.80 |
0.04 |
| T-helper cell differentiation |
AmiGO Browser |
23.80 |
0.04 |
| regulation of bone mineralization |
AmiGO Browser |
23.80 |
0.04 |
| response to external stimulus |
AmiGO Browser |
2.66 |
0.04 |
| regulation of DNA binding |
AmiGO Browser |
22.47 |
0.04 |
| natural killer cell mediated cytotoxicity |
AmiGO Browser |
22.47 |
0.04 |
| natural killer cell mediated immunity |
AmiGO Browser |
22.47 |
0.04 |
| vitamin transport |
AmiGO Browser |
22.47 |
0.04 |
| regulation of isotype switching |
AmiGO Browser |
22.47 |
0.04 |
| regulation of immune system process |
AmiGO Browser |
6.04 |
0.04 |
| regulation of immune response |
AmiGO Browser |
6.04 |
0.04 |
| eye photoreceptor cell differentiation |
AmiGO Browser |
21.29 |
0.05 |
| eye photoreceptor cell development |
AmiGO Browser |
21.29 |
0.05 |
| dicarboxylic acid transport |
AmiGO Browser |
21.29 |
0.05 |
| CD4-positive, alpha beta T cell differentiation |
AmiGO Browser |
21.29 |
0.05 |
| neutral amino acid transport |
AmiGO Browser |
21.29 |
0.05 |
| regulation of apoptosis |
AmiGO Browser |
2.58 |
0.05 |
| negative regulation of immune response |
AmiGO Browser |
20.23 |
0.05 |
| negative regulation of immune system process |
AmiGO Browser |
20.23 |
0.05 |
| T-helper 2 type immune response |
AmiGO Browser |
20.23 |
0.05 |
| photoreceptor cell development |
AmiGO Browser |
20.23 |
0.05 |
| interferon-gamma production |
AmiGO Browser |
20.23 |
0.05 |
| regulation of immune effector process |
AmiGO Browser |
20.23 |
0.05 |
| photoreceptor cell differentiation |
AmiGO Browser |
20.23 |
0.05 |
| myeloid cell differentiation |
AmiGO Browser |
5.70 |
0.05 |
| regulation of programmed cell death |
AmiGO Browser |
2.55 |
0.05 |
| phosphorylation |
AmiGO Browser |
2.29 |
0.05 |
| regulation of transforming growth factor beta receptor signaling pathway |
AmiGO Browser |
19.26 |
0.05 |
| leukocyte mediated cytotoxicity |
AmiGO Browser |
19.26 |
0.05 |
| L-fucose metabolic process |
AmiGO Browser |
19.26 |
0.05 |
| response to pain |
AmiGO Browser |
19.26 |
0.05 |
| positive regulation of cell proliferation |
AmiGO Browser |
3.59 |
0.05 |
| organ morphogenesis |
AmiGO Browser |
2.84 |
0.05 |
| peptidyl-amino acid modification |
AmiGO Browser |
5.36 |
0.05 |
| tube development |
AmiGO Browser |
5.32 |
0.05 |
| negative regulation of apoptosis |
AmiGO Browser |
3.52 |
0.06 |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains. |
AmiGO Browser |
17.59 |
0.06 |
| regulation of T cell differentiation |
AmiGO Browser |
17.59 |
0.06 |
| autophagy |
AmiGO Browser |
17.59 |
0.06 |
| exocrine system development |
AmiGO Browser |
17.59 |
0.06 |
| regulation of adaptive immune response |
AmiGO Browser |
17.59 |
0.06 |
| regionalization |
AmiGO Browser |
5.29 |
0.06 |
| cytokine production |
AmiGO Browser |
5.29 |
0.06 |
| negative regulation of programmed cell death |
AmiGO Browser |
3.50 |
0.06 |
| regulation of defense response |
AmiGO Browser |
16.18 |
0.06 |
| regulation of inflammatory response |
AmiGO Browser |
16.18 |
0.06 |
| positive regulation of locomotion |
AmiGO Browser |
16.18 |
0.06 |
| positive regulation of B cell activation |
AmiGO Browser |
16.18 |
0.06 |
| positive regulation of epithelial cell proliferation |
AmiGO Browser |
16.18 |
0.06 |
| positive regulation of cell motility |
AmiGO Browser |
16.18 |
0.06 |
| sex determination |
AmiGO Browser |
15.56 |
0.06 |
| cell killing |
AmiGO Browser |
15.56 |
0.06 |
| response to chemical stimulus |
AmiGO Browser |
2.68 |
0.06 |
| B cell proliferation |
AmiGO Browser |
14.98 |
0.06 |
| fucose metabolic process |
AmiGO Browser |
14.98 |
0.06 |
| protein tetramerization |
AmiGO Browser |
14.45 |
0.07 |
| alpha-beta T cell differentiation |
AmiGO Browser |
14.45 |
0.07 |
| BMP signaling pathway |
AmiGO Browser |
14.45 |
0.07 |
| fibroblast growth factor receptor signaling pathway |
AmiGO Browser |
14.45 |
0.07 |
| death |
AmiGO Browser |
2.11 |
0.07 |
| cell death |
AmiGO Browser |
2.11 |
0.07 |
| bone mineralization |
AmiGO Browser |
13.95 |
0.07 |
| cellular protein complex disassembly |
AmiGO Browser |
13.95 |
0.07 |
| organ development |
AmiGO Browser |
1.87 |
0.07 |
| inflammatory response |
AmiGO Browser |
3.17 |
0.07 |
| vasculogenesis |
AmiGO Browser |
13.48 |
0.07 |
| somatic recombination of immunoglobulin genes during immune response |
AmiGO Browser |
13.48 |
0.07 |
| isotype switching |
AmiGO Browser |
13.48 |
0.07 |
| somatic diversification of immunoglobulins during immune response |
AmiGO Browser |
13.48 |
0.07 |
| response to nutrient |
AmiGO Browser |
13.48 |
0.07 |
| macromolecular complex disassembly |
AmiGO Browser |
13.48 |
0.07 |
| immunoglobulin production during immune response |
AmiGO Browser |
13.48 |
0.07 |
| protein complex disassembly |
AmiGO Browser |
13.48 |
0.07 |
| regulation of lymphocyte differentiation |
AmiGO Browser |
13.48 |
0.07 |
| anatomical structure morphogenesis |
AmiGO Browser |
1.94 |
0.07 |
| somatic cell DNA recombination |
AmiGO Browser |
13.05 |
0.07 |
| regulation of ossification |
AmiGO Browser |
13.05 |
0.07 |
| prostaglandin metabolic process |
AmiGO Browser |
13.05 |
0.07 |
| somatic diversification of immune receptors via germline recombination within a single locus |
AmiGO Browser |
13.05 |
0.07 |
| prostanoid metabolic process |
AmiGO Browser |
13.05 |
0.07 |
| somatic recombination of immunoglobulin gene segments |
AmiGO Browser |
13.05 |
0.07 |
| leukocyte differentiation |
AmiGO Browser |
4.42 |
0.08 |
| brain development |
AmiGO Browser |
4.42 |
0.08 |
| regulation of response to stimulus |
AmiGO Browser |
12.64 |
0.08 |
| negative regulation of transport |
AmiGO Browser |
12.26 |
0.08 |
| eye morphogenesis |
AmiGO Browser |
12.26 |
0.08 |
| regulation of multicellular organismal process |
AmiGO Browser |
3.00 |
0.08 |
| somatic diversification of immunoglobulins |
AmiGO Browser |
11.90 |
0.08 |
| negative regulation of lymphocyte activation |
AmiGO Browser |
11.90 |
0.08 |
| somatic diversification of immune receptors |
AmiGO Browser |
11.90 |
0.08 |
| regulation of epithelial cell proliferation |
AmiGO Browser |
11.56 |
0.08 |
| epithelial cell proliferation |
AmiGO Browser |
11.24 |
0.09 |
| complement activation, classical pathway |
AmiGO Browser |
11.24 |
0.09 |
| alpha-beta T cell activation |
AmiGO Browser |
11.24 |
0.09 |
| tissue development |
AmiGO Browser |
2.90 |
0.09 |
| regulation of endocytosis |
AmiGO Browser |
10.93 |
0.09 |
| regulation of bone remodeling |
AmiGO Browser |
10.65 |
0.09 |
| regulation of B cell activation |
AmiGO Browser |
10.65 |
0.09 |
| humoral immune response mediated by circulating immunoglobulin |
AmiGO Browser |
10.65 |
0.09 |
| positive regulation of transcription factor activity |
AmiGO Browser |
10.65 |
0.09 |
| negative regulation of cell adhesion |
AmiGO Browser |
10.65 |
0.09 |
| defense response |
AmiGO Browser |
2.37 |
0.09 |
| regulation of cytokine production |
AmiGO Browser |
10.37 |
0.09 |
| immunoglobulin production |
AmiGO Browser |
10.37 |
0.09 |
| phagocytosis |
AmiGO Browser |
10.37 |
0.09 |
| regulation of binding |
AmiGO Browser |
9.87 |
0.10 |
| angiogenesis |
AmiGO Browser |
3.82 |
0.10 |
| cellular protein metabolic process |
AmiGO Browser |
1.48 |
0.10 |
| inner ear morphogenesis |
AmiGO Browser |
9.63 |
0.10 |
| cellular morphogenesis during differentiation |
AmiGO Browser |
3.78 |
0.10 |
| hexose metabolic process |
AmiGO Browser |
3.76 |
0.10 |
| positive regulation of lymphocyte proliferation |
AmiGO Browser |
9.41 |
0.10 |
| positive regulation of mononuclear cell proliferation |
AmiGO Browser |
9.41 |
0.10 |
| response to nutrient levels |
AmiGO Browser |
9.41 |
0.10 |
| response to hypoxia |
AmiGO Browser |
9.41 |
0.10 |
| pattern specification process |
AmiGO Browser |
3.71 |
0.10 |
| di-, tri-valent inorganic cation homeostasis |
AmiGO Browser |
3.71 |
0.10 |
| activation of plasma proteins during acute inflammatory response |
AmiGO Browser |
9.19 |
0.10 |
| complement activation |
AmiGO Browser |
9.19 |
0.10 |
| monosaccharide metabolic process |
AmiGO Browser |
3.68 |
0.10 |
L2L Microarray Analysis Tool